Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Clinical trial NCT00470535 · TERMINATED
Trial details
- NCT number
- NCT00470535
- Sponsor
- Roswell Park Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.